Diagnostic yield of patients with undiagnosed intellectual disability, global developmental delay and multiples congenital anomalies using karyotype, microarray analysis, whole exome sequencing from Central Brazil. 2022

Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
Genetics and Molecular Biology Graduate Program, Federal University of Goiás, Goiânia, Goiás, Brazil.

Intellectual Disability (ID) is a neurodevelopmental disorder that affects approximately 3% of children and adolescents worldwide. It is a heterogeneous and multifactorial clinical condition. Several methodologies have been used to identify the genetic causes of ID and in recent years new generation sequencing techniques, such as exome sequencing, have enabled an increase in the detection of new pathogenic variants and new genes associated with ID. The aim of this study was to evaluate exome sequencing with analysis of the ID gene panel as a tool to increase the diagnostic yield of patients with ID/GDD/MCA in Central Brazil, together with karyotype and CMA tests. A retrospective cohort study was carried out with 369 patients encompassing both sexes. Karyotype analysis was performed for all patients. CMA was performed for patients who did not present structural and or numerical alterations in the karyotype. Cases that were not diagnosed after performing karyotyping and CMA were referred for exome sequencing using a gene panel for ID that included 1,252 genes. The karyotype identified chromosomal alterations in 34.7% (128/369). CMA was performed in 83 patients who had normal karyotype results resulting in a diagnostic yield of 21.7% (18/83). Exome sequencing with analysis of the ID gene panel was performed in 19 trios of families that had negative results with previous methodologies. With the ID gene panel analysis, we identified mutations in 63.1% (12/19) of the cases of which 75% (9/12) were pathogenic variants,8.3% (1/12) likely pathogenic and in 16.7% (2/12) it concerned a Variant of Uncertain Significance. With the three methodologies applied, it was possible to identify the genetic cause of ID in 42.3% (156/369) of the patients. In conclusion, our studies show the different methodologies that can be useful in diagnosing ID/GDD/MCA and that whole exome sequencing followed by gene panel analysis, when combined with clinical and laboratory screening, is an efficient diagnostic strategy.

UI MeSH Term Description Entries
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002658 Developmental Disabilities Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed) Child Development Deviations,Child Development Disorders,Child Development Disorders, Specific,Developmental Delay Disorders,Disabilities, Developmental,Development Disorders, Child,Child Development Deviation,Child Development Disorder,Development Deviation, Child,Development Deviations, Child,Development Disorder, Child,Developmental Delay Disorder,Developmental Disability,Deviation, Child Development,Disability, Developmental
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073359 Exome Sequencing Techniques used to determine the sequences of EXONS of an organism or individual. Complete Exome Sequencing,Complete Transcriptome Sequencing,Whole Exome Sequencing,Whole Transcriptome Sequencing,Complete Exome Sequencings,Exome Sequencing, Complete,Exome Sequencing, Whole,Exome Sequencings, Complete,Sequencing, Complete Exome,Sequencing, Complete Transcriptome,Sequencing, Exome,Sequencing, Whole Exome,Sequencing, Whole Transcriptome,Transcriptome Sequencing, Complete,Transcriptome Sequencing, Whole,Transcriptome Sequencings, Complete
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
June 2023, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
July 2021, Clinical genetics,
Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
May 2022, Human mutation,
Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
June 2023, Molecular genetics & genomic medicine,
Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
June 2021, Journal of intellectual disability research : JIDR,
Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
January 2024, Pediatrics and neonatology,
Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
January 2021, Frontiers in genetics,
Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
April 2024, BMC genomics,
Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
October 2020, Cerebellum (London, England),
Ana Julia da Cunha Leite, and Irene Plaza Pinto, and Nico Leijsten, and Martina Ruiterkamp-Versteeg, and Rolph Pfundt, and Nicole de Leeuw, and Aparecido Divino da Cruz, and Lysa Bernardes Minasi
February 2020, Journal of child neurology,
Copied contents to your clipboard!